TTQ-F- PEG-RGD
4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline-polyethylene glycol-RGD
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-M-464 | 10mg | 800.00 | + Add to cart |
|
R-M-464 | 20mg | 975.00 | + Add to cart |
|
|
Product description
TTQ-PEG-RGD,4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline-polyethylene glycol-RGD from ruixi.TTQ-PEG-RGD has high nir-ii strength, good stability and affinity for activated platelets. It can be used to target glioma and thrombus, and distinguish fresh thrombus from old thrombus. It can also specifically target thrombosis in vivo and in vitro, which provides a potential tool for noninvasive diagnosis of early thrombosis.
Appearance | N/A |
---|---|
PEG Molecular weight | 1000/2000/3400/5000/10000 Dalton |
Purity | >90% |
Solubility | N/A |
PDI by GPC | <1.5 |
Abs | 739 nm |
Em | 997 nm |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product